JBF Capital, Inc. - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 16 filers reported holding HISTOGENICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JBF Capital, Inc. ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q3 2018$1,000
-50.0%
1,0000.0%0.00%
Q4 2017$2,0000.0%1,0000.0%0.00%
Q2 2017$2,0000.0%1,0000.0%0.00%
Q1 2017$2,0000.0%1,0000.0%0.00%
Q2 2016$2,0000.0%1,0000.0%0.00%
Q1 2016$2,000
-50.0%
1,0000.0%0.00%
Q4 2015$4,0000.0%1,0000.0%0.00%
-100.0%
Q3 2015$4,000
-33.3%
1,0000.0%0.00%0.0%
Q2 2015$6,000
-40.0%
1,0000.0%0.00%0.0%
Q1 2015$10,000
-9.1%
1,0000.0%0.00%
-50.0%
Q4 2014$11,0001,0000.00%
Other shareholders
HISTOGENICS CORP shareholders Q2 2016
NameSharesValueWeighting ↓
S Squared Technology, LLC 1,169,387$2,923,0002.32%
Abingworth LLP 888,889$2,204,0001.26%
Sofinnova Investments, Inc. 4,154,080$10,386,0000.66%
Third Security, LLC 2,690,570$6,726,0000.54%
Archon Capital Management LLC 293,090$733,0000.23%
Perceptive Advisors 2,203,277$5,508,0000.14%
Endurant Capital Management LP 56,177$140,0000.06%
Sio Capital Management, LLC 39,175$98,0000.05%
Palo Alto Investors LP 302,922$757,0000.03%
Rossmore Private Capital 11,236$28,0000.02%
View complete list of HISTOGENICS CORP shareholders